Holen Sie sich die Stockscreener-App
28.46
4.08%
-1.21
Handel nachbörslich:
28.46
Schlusskurs vom Vortag:
$29.67
Offen:
$29.46
24-Stunden-Volumen:
1.54M
Relative Volume:
1.01
Marktkapitalisierung:
$1.82B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-218.28M
KGV:
-7.9491
EPS:
-3.5803
Netto-Cashflow:
$-186.55M
1W Leistung:
-2.60%
1M Leistung:
-2.06%
6M Leistung:
+21.78%
1J Leistung:
-29.52%
1-Tages-Spanne:
$27.50
$29.90
1-Wochen-Bereich:
$27.50
$30.98
52-Wochen-Spanne:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
28.46 | 1.89B | 0 | -218.28M | -186.55M | -3.5803 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-16 | Eingeleitet | BofA Securities | Buy |
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
What MACD signals say about Vera Therapeutics Inc.July 2025 Analyst Calls & Precise Buy Zone Tips - newser.com
Is Vera Therapeutics Inc. still worth holding after the dipJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Historical volatility pattern of Vera Therapeutics Inc. visualizedEarnings Miss & Advanced Technical Signal Analysis - newser.com
How high can Vera Therapeutics Inc. stock goQuarterly Market Review & Weekly Return Optimization Plans - newser.com
How Vera Therapeutics Inc. stock benefits from strong dollar2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Can Vera Therapeutics Inc. stock maintain operating marginsJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Vera Therapeutics Inc. stock chart pattern explainedMarket Growth Report & Fast Moving Stock Trade Plans - newser.com
Ranking Vera Therapeutics Inc. among high performing stocks via toolsMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Can Vera Therapeutics Inc. hit a new high this monthQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Applying sector rotation models to Vera Therapeutics Inc.Market Volume Report & Technical Entry and Exit Tips - newser.com
Pivotal Week Ahead for Vera Therapeutics Investors - AD HOC NEWS
Applying Wyckoff theory to Vera Therapeutics Inc. stockJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com
How to build a custom watchlist for Vera Therapeutics Inc.Weekly Stock Recap & Weekly Stock Performance Updates - newser.com
Vera Therapeutics (VERA) to Release Earnings on Thursday - MarketBeat
How to interpret RSI for Vera Therapeutics Inc. stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
Will Vera Therapeutics Inc. stock continue dividend increasesWeekly Risk Report & Verified Entry Point Signals - newser.com
Building trade automation scripts for Vera Therapeutics Inc.2025 Momentum Check & Fast Gain Stock Tips - newser.com
Is Vera Therapeutics Inc. stock a buy before product launchesSell Signal & Reliable Entry Point Alerts - fcp.pa.gov.br
Real time alert setup for Vera Therapeutics Inc. performanceShare Buyback & AI Powered Market Entry Strategies - newser.com
Vera Therapeutics Advances Atacicept Study in Autoimmune Kidney Diseases - TipRanks
Vera Therapeutics Advances IgAN Treatment with Atacicept Study - TipRanks
Vera Therapeutics Advances Atacicept Study for IgAN: Key Insights for Investors - TipRanks
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):